NO884368L - Immunanalyse ved anvendelse av igg-innfangelsesantistoff og multippel, monoklonalt antistoffpaavisningssystem. - Google Patents

Immunanalyse ved anvendelse av igg-innfangelsesantistoff og multippel, monoklonalt antistoffpaavisningssystem.

Info

Publication number
NO884368L
NO884368L NO88884368A NO884368A NO884368L NO 884368 L NO884368 L NO 884368L NO 88884368 A NO88884368 A NO 88884368A NO 884368 A NO884368 A NO 884368A NO 884368 L NO884368 L NO 884368L
Authority
NO
Norway
Prior art keywords
antibody
citizing
igg
monoclonal antibody
disease system
Prior art date
Application number
NO88884368A
Other languages
English (en)
Norwegian (no)
Other versions
NO884368D0 (no
Inventor
Mark Norman Bobrow
George Cukor
Original Assignee
Du Pont
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont filed Critical Du Pont
Publication of NO884368D0 publication Critical patent/NO884368D0/no
Publication of NO884368L publication Critical patent/NO884368L/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/577—Immunoassay; Biospecific binding assay; Materials therefor involving monoclonal antibodies binding reaction mechanisms characterised by the use of monoclonal antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
NO88884368A 1987-10-02 1988-09-30 Immunanalyse ved anvendelse av igg-innfangelsesantistoff og multippel, monoklonalt antistoffpaavisningssystem. NO884368L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10364087A 1987-10-02 1987-10-02

Publications (2)

Publication Number Publication Date
NO884368D0 NO884368D0 (no) 1988-09-30
NO884368L true NO884368L (no) 1989-04-03

Family

ID=22296237

Family Applications (1)

Application Number Title Priority Date Filing Date
NO88884368A NO884368L (no) 1987-10-02 1988-09-30 Immunanalyse ved anvendelse av igg-innfangelsesantistoff og multippel, monoklonalt antistoffpaavisningssystem.

Country Status (5)

Country Link
EP (1) EP0310132A3 (da)
JP (1) JPH01163661A (da)
DK (1) DK546988A (da)
FI (1) FI884505L (da)
NO (1) NO884368L (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6200764B1 (en) 1985-01-29 2001-03-13 Bayer Corporation Detection, quantitation and classification of ras proteins in body fluids and tissues
US5443956A (en) * 1985-01-29 1995-08-22 Oncogene Science, Inc. Detection, quantitation and classification of RAS proteins in body fluids and tissues
GB2270158B (en) * 1992-08-03 1997-03-19 Marconi Gec Ltd Detection
WO1994003811A1 (en) * 1992-08-03 1994-02-17 Gec-Marconi Limited Immunological detection using two detectable labels
NZ291153A (en) * 1994-07-25 1999-01-28 Boehringer Mannheim Gmbh Determination of a specific antibody using multiple antigens containing several epitope regions which react with the antibody
GB0109925D0 (en) * 2001-04-23 2001-06-13 Axis Shield Asa Method
US20050069962A1 (en) 2001-10-12 2005-03-31 Archer Robert M Antibody complexes and methods for immunolabeling
US8323903B2 (en) 2001-10-12 2012-12-04 Life Technologies Corporation Antibody complexes and methods for immunolabeling
US20040018577A1 (en) * 2002-07-29 2004-01-29 Emerson Campbell John Lewis Multiple hybrid immunoassay
WO2008036802A2 (en) * 2006-09-21 2008-03-27 Prometheus Laboratories Inc. Antibody-based arrays for detecting multiple signal transducers in rare circulating cells
BRPI0717416A2 (pt) 2006-09-21 2013-11-12 Prometheus Lab Inc Método para realizar um imunoensaio complexo de alta produtividade, e, arranjo
BRPI0813583A2 (pt) 2007-07-13 2014-12-30 Prometheus Lab Inc Métodos para selecionar um medicamento anticâncer, para identificar a resposta de um tumor pulmonar, e para prognosticar a resposta de um paciente, e, arranjo
NZ600339A (en) 2008-02-25 2013-12-20 Nestec Sa Drug selection for breast cancer therapy using antibody-based arrays
AU2010273319B2 (en) 2009-07-15 2015-01-22 Nestec S.A. Drug selection for gastric cancer therapy using antibody-based arrays
US9719995B2 (en) 2011-02-03 2017-08-01 Pierian Holdings, Inc. Drug selection for colorectal cancer therapy using receptor tyrosine kinase profiling
WO2013033623A1 (en) 2011-09-02 2013-03-07 Nestec S.A. Profiling of signal pathway proteins to determine therapeutic efficacy
JP6345655B2 (ja) 2012-07-03 2018-06-20 ワシントン・ユニバーシティＷａｓｈｉｎｇｔｏｎ Ｕｎｉｖｅｒｓｉｔｙ タウに対する抗体
TW202136296A (zh) 2014-06-27 2021-10-01 美商Ｃ２Ｎ醫療診斷有限責任公司 人類化抗-tau抗體
CN104730251B (zh) * 2014-11-28 2016-11-23 威海纽普生物技术有限公司 肌钙蛋白i检测试剂盒及检测方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL185309C (nl) * 1980-07-28 1990-03-01 Akzo Nv Methode voor het bepalen van antigenen met behulp van twee of meer monoklonale antilichamen alsmede immuunreagens.
SE8006424L (sv) * 1980-09-12 1982-03-13 Jolla Cancer Res Found Sett att bestemma ett antigen i losning
US4514505A (en) * 1982-05-21 1985-04-30 The Trustees Of Columbia University In The City Of New York Monoclonal antibody mixtures and use thereof for enhanced sensitivity immunoassays
US4595661A (en) * 1983-11-18 1986-06-17 Beckman Instruments, Inc. Immunoassays and kits for use therein which include low affinity antibodies for reducing the hook effect

Also Published As

Publication number Publication date
DK546988D0 (da) 1988-09-30
NO884368D0 (no) 1988-09-30
JPH01163661A (ja) 1989-06-27
FI884505A0 (fi) 1988-09-30
FI884505A7 (fi) 1989-04-03
EP0310132A2 (en) 1989-04-05
EP0310132A3 (en) 1990-10-10
DK546988A (da) 1989-04-03
FI884505L (fi) 1989-04-03

Similar Documents

Publication Publication Date Title
DE68914244D1 (de) Monoklonaler Antikörper.
DE3883899D1 (de) Geänderte antikörper.
DE3854502D1 (de) Gegen hiv-antigene spezifischer monoklonaler antikörper.
FI925631L (fi) Monoklonala antikroppar
DE3885355D1 (de) Monoklonale Antikörper.
FI884505A7 (fi) Immunoanalyysi, jossa käytetään IgG-sieppaajavasta-ainetta ja monen monoklonaalisen vasta-aineen osoitusjärjestelmä.
DK63187D0 (da) Krydsbeskyttende monoklonale antistofpraeparater
DE69017756D1 (de) Infrarotanalyseverfahren.
DE3788148D1 (de) Monoklonale Antikörper und deren Verwendung.
NO884834D0 (no) Disvovelanaloger av ll-e33288-antitumormidler.
DK169987D0 (da) Human tumor-associated antigen, ca-ou1
NO862920L (no) Onkofetale spesifikke monoklonale antistoffer, fremgangsmaate for fremstilling og anvendelse.
DE3888437D1 (de) Immobilisierte Antikörper.
EP0307476A4 (en) Bilirubin antigen, monoclonal antibody therefor, process for their preparation, and their use
DE3587714D1 (de) Menschliches alpha 2-Plasmin spezifischer monoklonaler Antikörper.
DE3780256D1 (de) Anti-pci-monoklonaler antikoerper.
DK69690D0 (da) Humane anti-rh(d) monoklonale antistoffer
NO881239D0 (no) Analyse for detektering av hepatitt-antigener og aids-antistoffer.
DE3888604D1 (de) Monoklonale Antikörper gegen Antithrombinbindende Substanz und seine Verwendungen.
DK717888D0 (da) Monoklonale antistoffer
NO890116L (no) Monoklonale antistoffer.
DK69590D0 (da) Humane anti-rh(d) monoklonale antistoffer
NO873488L (no) Monoklonale antistoffer.
EP0229107A4 (en) PROTECTIVE HUMAN MONOCLONAL ANTIBODIES TO -i(PSEUDOMONAS AERUGINOSA) EXOTOXIN A.
DE3687542D1 (de) Monoklonaler antikoerper gegen humanes protein c.